Skip to content
GLP-1 Savers
Menu
Ranked #255 · Watch List

Oria Meds review

Compounded semaglutide at $199 a month and tirzepatide at $369, advertised as $149 and $249 — two figures that appear nowhere in the signup — on a public site that never names either molecule.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

$199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The homepage sells "starting at $149" and "starting at $249". Neither figure appears anywhere in the signup, in either state tested. What the signup actually offers is $199, $209 and $209 a month for semaglutide and $369, $316 and $299 for tirzepatide — and the semaglutide ladder is inverted, so committing to three or six months costs $10 a month more than not committing. Neither molecule is named anywhere on the public site: semaglutide and tirzepatide first appear at the second step of the signup, after a name, an email, a phone number and a shipping address have been collected. A second price table sits unrendered in the homepage code with different figures again.

How much does Oria Meds cost?

The price Oria Meds publishes is $199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup). Tirzepatide is listed at $369/mo month-to-month (four-week supply; three and six months cost $316 and $299 a month). We flag this one to watch: confirm the ongoing rate with Oria Meds before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$199/mo month-to-month (four-week supply; the $149 on its homepage matches no plan in the signup)
Tirzepatide
$369/mo month-to-month (four-week supply; three and six months cost $316 and $299 a month)
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

The Value Score card

Oria Meds scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait30/100
Both Molecules92/100
Nationwide Availability72/100
Easy Cancellation82/100
Reputation69/100

Why it's a deal

  • The full ladder appears in the signup before payment, with each plan's dose schedule and supply length attached: a four-week supply at $199 or $369, and twelve- and twenty-four-week gradual-start plans beside them
  • The dispensing pharmacy is named with a street address, a phone number, an email address and a website — a level of naming several better-priced desks in this batch do not match
  • The provider network is named on the about page, in the privacy policy and in the subpage footers, so the clinical side is attributable to something
  • Cancellation is through the patient portal or by email, stops all future charges, and is described as month-to-month with no long-term contract
  • A mailing address is published on every page, and the plans state how often medication ships rather than leaving it to be discovered

Read the fine print

  • The two prices on the homepage are not sold. "Starting at $149" and "starting at $249" appear nowhere in the signup, which was walked in two different states and returned the same ladder both times
  • The semaglutide ladder is inverted: one month is $199 and both the three- and six-month plans work out to $209 a month, so committing longer costs more
  • Neither molecule is named anywhere on the public site. Semaglutide and tirzepatide first appear at the second step of the signup, after a name, an email address, a phone number and a shipping address have been collected
  • A second price table lives in the homepage code and renders nowhere, carrying different figures again for the same programs
  • No legal entity, no state of organization and no governing law is published anywhere on the site — the only address is a suite widely used for registered-agent filings
  • No clinician is named and no identifier is published for the provider network
  • The pharmacy class appears only inside an unrendered script; a reader is told only that a licensed compounding pharmacy is used
  • Two different scarcity counters run on consecutive screens, and the promised review turnaround is twenty-four hours on one screen and forty-eight on the next
  • "Cancel anytime" sits beside terms saying medication is not refundable once dispensed, including partially used or unopened vials

The bottom line

Best for: Readers willing to hand over a name, an email and a shipping address before learning which drug is being sold and what it costs. Compounded semaglutide at $199 a month and tirzepatide at $369, advertised as $149 and $249 — two figures that appear nowhere in the signup — on a public site that never names either molecule.

Ranked #255 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to Oria Meds, out of 417 others we track.

Shopping Oria Meds against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Oria Meds, and every program that undercuts or outscores it — starting with VirtualCare2Go, the closest match on score — is ranked on the Oria Meds alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Oria Meds's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Oria Meds's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals